About Inogen, Inc.
https://www.inogen.comInogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
CEO
Kevin R. M. Smith
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 63
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:1.69M
Value:$10.83M
BLACKROCK INC.
Shares:1.63M
Value:$10.46M
VANGUARD GROUP INC
Shares:1.43M
Value:$9.17M
Summary
Showing Top 3 of 199
About Inogen, Inc.
https://www.inogen.comInogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $92.39M ▲ | $54.07M ▲ | $-5.29M ▼ | -5.73% ▼ | $-0.2 ▼ | $-221K ▼ |
| Q2-2025 | $92.28M ▲ | $47.47M ▲ | $-4.15M ▲ | -4.5% ▲ | $-0.15 ▲ | $911K ▲ |
| Q1-2025 | $82.28M ▲ | $44.03M ▼ | $-6.17M ▲ | -7.5% ▲ | $-0.25 ▲ | $-2.47M ▲ |
| Q4-2024 | $80.08M ▼ | $47.67M ▼ | $-9.76M ▼ | -12.18% ▼ | $-0.41 ▼ | $-6.31M ▼ |
| Q3-2024 | $88.83M | $49.14M | $-5.96M | -6.71% | $-0.25 | $-2.48M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $124.5M ▲ | $307.01M ▼ | $109.83M ▼ | $197.18M ▼ |
| Q2-2025 | $122.43M ▲ | $312.04M ▲ | $112.55M ▲ | $199.49M ▲ |
| Q1-2025 | $118.89M ▲ | $308.41M ▲ | $110.46M ▼ | $197.95M ▲ |
| Q4-2024 | $113.8M ▼ | $296.19M ▼ | $122.33M ▲ | $173.86M ▼ |
| Q3-2024 | $120.66M | $306.17M | $120.77M | $185.4M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-5.29M ▼ | $2.17M ▼ | $-82K ▲ | $418K ▲ | $2.8M ▲ | $64K ▼ |
| Q2-2025 | $-4.15M ▲ | $4.35M ▲ | $-22.57M ▼ | $0 ▼ | $-17.58M ▼ | $480K ▲ |
| Q1-2025 | $-6.17M ▲ | $-16.79M ▼ | $-2.04M ▼ | $23.95M ▲ | $5.12M ▼ | $-18.83M ▼ |
| Q4-2024 | $-9.76M ▼ | $-3.02M ▼ | $11.54M ▲ | $-260K ▼ | $8.13M ▲ | $-6.16M ▼ |
| Q3-2024 | $-5.96M | $6.99M | $305K | $441K | $7.8M | $2.14M |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $60.00M ▲ | $40.00M ▼ | $30.00M ▼ | $40.00M ▲ |
 UNITED STATES | $110.00M ▲ | $60.00M ▼ | $50.00M ▼ | $50.00M ▲ |
CEO
Kevin R. M. Smith
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 63
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:1.69M
Value:$10.83M
BLACKROCK INC.
Shares:1.63M
Value:$10.46M
VANGUARD GROUP INC
Shares:1.43M
Value:$9.17M
Summary
Showing Top 3 of 199